In an animal model of amyotrophic lateral sclerosis (ALS), it was previously found that regulating the level of IGF-1 could reduce motor neuron death, delay the course of the disease, and delay the occurrence of muscle atrophy (Lin et al., 2018). Here, IGF1 is linked to amyotrophic lateral sclerosis.